Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SRY-box 15 pseudogene (ENSG00000255369) is a nonfunctional genomic element with high sequence similarity to the SRY-box transcription factor 15 (SOX15), but it lacks the capacity to encode a functional protein due to inactivating mutations. Pseudogenes are generally classified as nonfunctional genomic relics, although recent research suggests some may exert subtle regulatory effects at the RNA level or via sequence competition. However, there is no evidence that this specific pseudogene serves as a direct therapeutic target or has a defined role in disease. Its classification as a pseudogene means it should not be confused with the protein-coding SRY-box transcription factor 15 gene, which has confirmed functions in transcriptional regulation and development[2][3]. This entry refers to a pseudogene, not a protein-coding gene or therapeutic target. Pseudogenes like the SRY-box 15 pseudogene are primarily characterized by nonfunctionality, though emerging research shows rare regulatory roles for some pseudogenes[2][3]. There is no evidence for drug interactions, biomarker use, or relevance as a direct therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SRY-box 15 pseudogene.